Comparison
21q22 11q22 12 Microdeletion Syndrome C5192593 vs 16p13 11 Microduplication Syndrome C4304595
Clinical comparison between 21q22 11q22 12 Microdeletion Syndrome and 16p13 11 Microduplication Syndrome for differential diagnosis and treatment planning.
21q22 11q22 12 Microdeletion Syndrome C5192593
A rare genetic condition involving deletion of a specific region on chromosome 21. It may cause developmental delay, intellectual disability, and distinctive facial features. Management focuses on developmental support and medical monitoring.
16p13 11 Microduplication Syndrome C4304595
A rare genetic condition from duplication of a segment on chromosome 16. Features may include developmental delays and learning differences. Management focuses on supportive care and early intervention.
6 comparison axes
Onset
21q22 11q22 12 Microdeletion Syndrome C5192593
0-0
16p13 11 Microduplication Syndrome C4304595
0-null
Onset patterns differ
Severity
21q22 11q22 12 Microdeletion Syndrome C5192593
severe
16p13 11 Microduplication Syndrome C4304595
moderate
Different severity levels
Chronic
21q22 11q22 12 Microdeletion Syndrome C5192593
Chronic
16p13 11 Microduplication Syndrome C4304595
Chronic
Differing course
Communicable
21q22 11q22 12 Microdeletion Syndrome C5192593
No
16p13 11 Microduplication Syndrome C4304595
No
Different transmission
Body System
21q22 11q22 12 Microdeletion Syndrome C5192593
congenital
16p13 11 Microduplication Syndrome C4304595
congenital
Same/different system
Category
21q22 11q22 12 Microdeletion Syndrome C5192593
rare-disease
16p13 11 Microduplication Syndrome C4304595
genetic
Different category
Bottom line
21q22-11q22-12-microdeletion-syndrome-C5192593 and 16p13-11-microduplication-syndrome-C4304595 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 21q22 11q22 12 Microdeletion Syndrome C5192593 | 16p13 11 Microduplication Syndrome C4304595 | Discriminating power |
|---|---|---|---|
| Developmental delay | May include developmental delay; source labels overall severity as severe. | May include developmental delay or learning differences; source labels severity as moderate. | Low |
| Intellectual or learning function | Intellectual disability is described as a possible feature. | Learning differences are described; intellectual disability is not established by the source. | Moderate |
| Facial appearance | Distinctive facial features may occur, but specific features are not supplied. | No distinctive facial pattern is established in the supplied description. | Low |
When to favor each condition
Choose 21q22 11q22 12 Microdeletion Syndrome C5192593 when
A confirmed deletion involving 21q22.11–q22.12
The genomic interval and deletion type define this condition rather than symptoms alone.
High
Developmental delay with possible intellectual disability and facial differences
This pattern may prompt testing, but it does not by itself establish the diagnosis.
Low
Need to explain a severe congenital presentation
The supplied severity label is severe, yet individual prognosis remains variable and clinician-dependent.
Moderate
Choose 16p13 11 Microduplication Syndrome C4304595 when
A confirmed duplication involving 16p13.11
The chromosome 16 interval and duplication type distinguish it from a chromosome 21 deletion.
High
Developmental delay or learning differences without a defined deletion
These nonspecific features may fit the source description but require genomic confirmation.
Low
Counseling when severity is described as moderate
Use the moderate label cautiously; penetrance and individual impact are not established here.
Moderate
How key tests differ
| Test | 21q22 11q22 12 Microdeletion Syndrome C5192593 | 16p13 11 Microduplication Syndrome C4304595 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May detect a deletion at 21q22.11–q22.12. | May detect a duplication at 16p13.11. | The copy-number change and locus, not symptoms, separate the findings; laboratory confirmation is required. |
| Karyotype | May miss a small deletion. | May miss a small duplication. | A normal karyotype does not exclude either micro-copy-number condition. |
| Developmental assessment | May document delay or intellectual disability. | May document delay or learning differences. | Assessments describe function but cannot identify the chromosomal change. |
Prognosis comparison
21q22 11q22 12 Microdeletion Syndrome C5192593
- Outcome
- A chronic congenital condition with potentially substantial developmental impact; exact outcome is not established.
- Factors
- Deletion confirmation, developmental profile, and associated medical findings interpreted by clinicians.
16p13 11 Microduplication Syndrome C4304595
- Outcome
- A chronic condition that may involve learning or developmental differences; exact outcome is not established.
- Factors
- Duplication confirmation, learning profile, and any clinician-identified associated findings.
Time frame: Often recognized in infancy or childhood; onset data for the duplication are incomplete.
Neither is communicable. No reliable mortality or prevalence comparison is supplied.
Complications comparison
| Complication | Presentation |
|---|---|
| Learning and development needs | Support needs may be substantial when intellectual disability is present. Learning support may be needed; extent is not established. Neither source specifies complication rates. |
| Associated medical problems | Monitoring is advised, but specific organ complications are not supplied. Specific medical complications are not established in the source. Do not infer unlisted anomalies or mortality. |
| Family recurrence concerns | Inheritance and recurrence cannot be determined from the description alone. Inheritance and recurrence cannot be determined from the description alone. Genetic counseling should interpret parental testing when available. |
Patient education highlights
- HighDiagnosis depends on genetics
Similar developmental features can have many causes; only an appropriate genetic test can distinguish these conditions.
- HighSupportive care
Management described for both centers on developmental support, early intervention, and individualized medical monitoring.
- MediumVariable presentation
Not every person has every feature. Avoid using severity labels to predict a specific outcome without clinical assessment.